[HTML][HTML] Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a
… cancer progression [7]. Presently, the mechanistic contributions of most of these proteins
towards cancer … Breast cancer cells devoid of PC4 show dysregulated expression of critical …
towards cancer … Breast cancer cells devoid of PC4 show dysregulated expression of critical …
[HTML][HTML] SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 …
K Jiang, J Li, J Zhang, L Wang, Q Zhang, J Ge… - International …, 2019 - Elsevier
Immune checkpoint inhibitors, such as anti-PD-1/PD-L1, are a novel class of inhibitors that
function as a tumor suppressing factor via modulation of immune cell-tumor cell interaction. …
function as a tumor suppressing factor via modulation of immune cell-tumor cell interaction. …
High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma
K Ogushi, T Yokobori, S Nobusawa, T Shirakura… - Cancers, 2023 - mdpi.com
… of the anti-tumor effect of STMN1 silencing. Moreover, the … dysregulation based on microtubule
dynamics dysfunction is the main mechanism of the anti-tumor effect of STMN1 silencing. …
dynamics dysfunction is the main mechanism of the anti-tumor effect of STMN1 silencing. …
癌症中microRNAs 和表观遗传之间的相互调控作用
唐德平, 姚慧慧, 唐金舟, 毛爱红 - 生物技术通报, 2020 - biotech.aiijournal.com
… of miRNAs and epigenetics,and particularly focus on illuminating how epigenetics can affect
the miRNAs expression,as well as how miRNAs can control epigenetics in human cancer. …
the miRNAs expression,as well as how miRNAs can control epigenetics in human cancer. …
Los fármacos epigenéticos isotretinoína y talidomida modifican la expresión de genes y proteínas relacionadas con la etiología, desarrollo y pronóstico del cáncer en …
PN Ramírez Flores - 2020 - eprints.uanl.mx
… Hepatocellular carcinoma (HCC) is the fourth cause of … in tumor suppressor genes, stability
genes, and/or oncogenes. A therapeutic approach for cancer is the use of epigenetic drugs …
genes, and/or oncogenes. A therapeutic approach for cancer is the use of epigenetic drugs …